Genetic Polymorphisms in the TGF-β1 Gene and Breast Cancer Survival: A Report from the Shanghai Breast Cancer Study

Cancer Research

Volumn 64, Issue 3, 2004, Pages 836-839

  Shu, Xiao Ou ^a,c   Gao, Yu Tang ^b   Cai, Qiuyin ^a   Pierce, Larry ^a   Cai, Hui ^a   Ruan, Zhi Xian ^b   Yang, Gong ^a   Jin, Fan ^b   Zheng, Wei ^a  

^a VANDERBILT INGRAM CANCER CENTER   (United States)

^b SHANGHAI CANCER INSTITUTE   (China)

^c VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; TAMOXIFEN;

ADULT; ALLELE; ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER SURVIVAL; CHINA; CODON; COHORT ANALYSIS; DNA SEQUENCE; FEMALE; FOLLOW UP; GENE; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROMOTER REGION; SURVIVAL RATE; TRANSCRIPTION INITIATION SITE; TRANSFORMING GROWTH FACTOR BETA1 GENE;

ADULT; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MIDDLE AGED; POLYMORPHISM, GENETIC; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 0842282633     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-03-3492     Document Type: Article

References (23)

1. Blobe, G. C., Schiemann, W. P., and Lodish, H. F. Role of transforming growth factor β1 in human disease. N. Engl. J. Med., 342: 1350-1358, 2000.
2. Armstrong, K. Genetic susceptibility to breast cancer: from the roll of the dice to the hand women were dealt. J. Am. Med. Assoc., 285: 2907-2909, 2001.
3. Barcellos-Hoff, M. H., and Ewan, K. B. Transforming growth factor-β1 and breast cancer: mammary gland development. Breast Cancer Res., 2: 92-99, 2000.
4. Dumont, N., and Arteaga, C. L. Transforming growth factor-β and breast cancer: tumor promoting effects of transforming growth factor-β. Breast Cancer Res., 2: 125-132, 2000.
5. Muraoka, R. S., Dumont, N., Ritter, C. A., Dugger, T. C., Brantley, D. M., Chen, J., Easterly, E., Roebuck, L. R., Ryan, S., Gotwals, P. J., Koteliansky, V., and Arteaga, C. L. Blockade of TGF-β inhibits mammary tumor cell viability, migration, and metastases. J. Clin. Investig., 109: 1551-1559, 2002.
6. Nakata, D., Hamada, J., Ba, Y., Matsushita, K., Shibata, T., Hosokawa, M., and Moriuchi, T. Enhancement of tumorigenic, metastatic and in vitro invasive capacity of rat mammary tumor cells by transforming growth factor-β. Cancer Lett., 175: 95-106, 2002.
7. Siegel, P. M., Shu, W., Cardiff, R. D., Muller, W. J., and Massague, J. Transforming growth factor β signaling impairs Neu-induced mammary tumorigenesis while promoting pulmonary metastasis. Proc. Natl. Acad. Sci. USA, 100: 8430-8435, 2003.
8. Gao, Y. T., Shu, X. O., Dai, Q., Potter, J. D., Brinton, L. A., Wen, W., Sellers, T. A., Kushi, L. H., Ruan, Z., Bostick, R. M., Jin, F., and Zheng, W. Association of menstrual and reproductive factors with breast cancer risk: results from the Shanghai Breast Cancer Study. Int. J. Cancer, 87: 295-300, 2000.
9. Grainger, D. J., Heathcote, K., Chiano, M., Snieder, H., Kemp, P. R., Metcalfe, J. C., Carter, N. D., and Spector, T. D. Genetic control of the circulating concentration of transforming growth factor type β1. Hum. Mol. Genet., 8: 93-97, 1999.
10. Yokota, M., Ichihara, S., Lin, T. L., Nakashima, N., and Yamada, Y. Association of a T29→C polymorphism of the transforming growth factor-β1 gene with genetic susceptibility to myocardial infarction in Japanese. Circulation, 101: 2783-2787, 2000.
11. Dunning, A. M., Ellis, P. D., McBride, S., Kirschenlohr, H. L., Healey, C. S., Kemp, P. R., Luben, R. N., Chang-Claude, J., Mannermaa, A., Kataja, V., Pharoah, P. D., Easton, D. F., Ponder, B. A., and Metcalfe, J. C. A transforming growth factor β signal peptide variant increases secretion in vitro and is associated with increased incidence of invasive breast cancer. Cancer Res., 63: 2610-2615, 2003.
12. Ziv, E., Cauley, J., Morin, P. A., Saiz, R., and Browner, W. S. Association between the T29→C polymorphism in the transforming growth factor β1 gene and breast cancer among elderly white women: the study of osteoporotic fractures. J. Am. Med. Assoc., 285: 2859-2863, 2001.
13. Akhurst, R. J. TGF-β antagonists: why suppress a tumor suppressor? J. Clin. Investig., 109: 1533-1536, 2002.
14. Tang, B., Vu, M., Booker, T., Santner, S. J., Miller, F. R., Anver, M. R., and Wakefield, L. M. TGF-β switches from tumor suppressor to prometastatic factor in a model of breast cancer progression. J. Clin. Investig., 112: 1116-1124, 2003.
15. Teicher, B. A. Malignant cells, directors of the malignant process: role of transforming growth factor-β. Cancer Metastasis Rev., 20: 133-143, 2001.
16. Goode, E. L., Dunning, A. M., Kuschel, B., Healey, C. S., Day, N. E., Ponder, B. A., Easton, D. F., and Pharoah, P. P. Effect of germ-line genetic variation on breast cancer survival in a population-based study. Cancer Res., 62: 3052-3057, 2002.
17. Ivanovic, V., Todorovic-Rakovic, N., Demajo, M., Neskovic-Konstantinovic, Z., Subota, V., Ivanisevic-Milovanovic, O., and Nikolic-Vukosavljevic, D. Elevated plasma levels of transforming growth factor-β1 (TGF-β1) in patients with advanced breast cancer: association with disease progression. Eur. J. Cancer, 39: 454-461, 2003.
18. Kong, F. M., Anscher, M. S., Murase, T., Abbott, B. D., Iglehart, J. D., and Jirtle, R. L. Elevated plasma transforming growth factor-β1 levels in breast cancer patients decrease after surgical removal of the tumor. Ann. Surg., 222: 155-162, 1995.
19. Decensi, A., Torrisi, R., Fontana, V., Barreca, A., Ponzani, P., Pensa, F., Parodi, S., and Costa, A. Correlation between plasma transforming growth factor-β1 and second primary breast cancer in a chemoprevention trial. Eur. J. Cancer, 34: 999-1003, 1998.
20. Sminia, P., Barten, A. D., van Waarde, M. A., Vujaskovic, Z., and van Tienhoven, G. Plasma transforming growth factor β levels in breast cancer patients. Oncol. Rep., 5: 485-488, 1998.
21. Wakefield, L. M., Letterio, J. J., Chen, T., Danielpour, D., Allison, R. S., Pai, L. H., Denicoff, A. M., Noone, M. H., Cowan, K. H., O'Shaughnessy, J. A., and Transforming growth factor-β1 circulates in normal human plasma and is unchanged in advanced metastatic breast cancer. Clin. Cancer Res., 1: 129-136, 1995.
22. Kajdaniuk, D., Marek, B., Swietochowska, E., Ostrowska, Z., Glogowska-Szelag, J., Kos-Kudla, B., Ciesielska-Kopacz, N., and Wielkoszyski, T. Plasma transforming growth factor β1 in breast cancer patients treated with CMF chemotherapy. J. Clin. Pharm. Ther., 25: 291-294, 2000.
23. Grainger, D. J., Mosedale, D. E., and Metcalfe, J. C. TGF-β in blood: a complex problem. Cytokine Growth Factor Rev., 11: 133-145, 2000.